Neurocrine Biosciences Stock Price (NASDAQ:NBIX)

Add to My Stocks
$41.98 $0.48 (1.16%) NBIX stock closing price Mar 24, 2017 (Closing)
YOUR DAILY UPDATE ON
NBIX
Neurocrine Biosciences
24 MAR 2017
amigobulls logo
NBIX hand_up
NBIX vs S&P 500
Closing Price: Mar 24, 2017
NBIX
$41.98 ( 1.16%)
S&P 500
2344 ( -0.08%)
NBIX
52 Week Price Range
1 Year Return: 17.46%
Q4 Growth*
Poor
Profitable ?
No
net image
2016 Q4 Net Loss
-940.6%
Pays Dividend ?
Yes
dividend
12 Months Dividend
  : $0
Dividend Yield
  : -99900%
home image
Rating
NBIX POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Neurocrine Biosciences Snapshot Video

10 5 2

NBIX Stock Details

Prev Close* : $41.50
Market Cap:
$3.62B
Day Low: $41.38
52 Week Low: $33.56
Open: $41.65
Volume: 462606
Day High: $42.26
52 Week High: $55.15
Dividend:
N/A

Neurocrine Biosciences Stock Articles & Video

more news on NBIX stock

Neurocrine Biosciences News - From Partners

NBIX Stockcharts

View NBIX PE ratio, PS ratio stocks charts and compare with peers.
NBIX Chart
Note: Compare Neurocrine Biosciences stock price history with the index and industry peers.

Neurocrine Biosciences Financial Ratios

Receivables Turnover
4.97

NBIX Industry Peers

Company Price Change (%)
Patheon Nv (PTHN)26.180.23 (0.87%)
Valeant Pharmaceuticals Intl Inc (VRX)10.750.11 (1.01%)
Abbvie (ABBV)65.620.03 (0.05%)
Repros Therapeutics (RPRX)1.160.02 (1.69%)
Auspex Pharma (ASPX)100.960 (0%)
Sage Therapeutics (SAGE)62.492.6 (3.99%)
Pfizer (PFE)340.29 (0.85%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)7.40.32 (4.52%)
Tesaro Inc (TSRO)1606.38 (4.15%)
Ignyta (RXDX)9.250.35 (3.93%)
Flexion Therapeutics (FLXN)27.271.02 (3.89%)
BioCryst Pharma (BCRX)8.7850.3 (3.53%)
Xencor (XNCR)24.530.82 (3.46%)
Infinity Pharma (INFI)3.30.1 (3.13%)
Top gainers from Medical-Drugs industry
* As of Mar 25, 2017
CompanyPriceChange (%)
MediWound (MDWD)6.40.27 (4.04%)
Nature's Sunshine Products (NATR)9.150.35 (3.68%)
Esperion Therapeutics (ESPR)38.941.46 (3.61%)
Merus Labs International (MSLI)0.860.03 (3.37%)
Concert Pharma (CNCE)17.3950.48 (2.68%)
GlycoMimetics (GLYC)5.560.12 (2.11%)
Aralez Pharma (ARLZ)2.190.04 (1.79%)
Top losers from Medical-Drugs industry
* As of Mar 25, 2017

Neurocrine Biosciences, Inc. Stock News - Partner Headlines

Neurocrine Biosciences Financial Statements

income statement20162015201420132012
Net Sales Or Revenues15M19.76M-2.91M53.14M
Net Income-141.09M-88.92M-60.54M-46.09M5.02M
Total Operating Expense162.37M113.97M64.4M52.58M51.68M
view Neurocrine Biosciences, Inc. income statement
balance sheet20162015201420132012
Total Assets365.08M474.78M243.03M154.67M195.97M
Total Liabilities50.2M50.33M34.33M34.26M41.6M
Shareholders Equity314.87M424.45M208.69M120.41M154.37M
view Neurocrine Biosciences, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities5.78M8.7M1.6M12.23M-13.36M
Net Cash From (Used By) Operating Activities-106.18M-37.99M-47.14M-29.6M-35.29M
Increase (Decrease) In Prop Plant And Equipment-4.09M-1.92M-1.56M-0.5M-0.93M
view Neurocrine Biosciences, Inc. cashflow statement

Neurocrine Biosciences Stock Message Board

Neurocrine Biosciences stock lost 1.16 %, and the last close price as of 24 Mar, 2017 is 41.98 for NBIX stock. Looking at Neurocrine Biosciences market capitalization, which currently stands at 3.62B, we can say that NBIX stock is a Mid cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Neurocrine Biosciences stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy NBIX stock than sell it, then Neurocrine Biosciences stock price goes up. Conversely, if more investors wanted to sell NBIX stock than buy it, there would be greater supply than demand, and the stock price would fall. 462606 NBIX shares were traded yesterday, and Neurocrine Biosciences stock chart shows that the NBIX stock quote hit a day high of 42.26 and day low of 41.38. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. One can observe stock price trends and check for volatility by checking Neurocrine Biosciences stock price history.